<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    Reckitt Benckiser Group Plc.

    Reckitt Benckiser Group Plc.

    RB is the global leading consumer health, hygiene and home company. Driven by a pu...

    RB is the global leading consumer health, hygie...

    Filing Type:    PU
    Oneva, Inc.

    Oneva, Inc.

    Today's adults juggle caring for aging parents and children while working full-tim...

    Today's adults juggle caring for aging parents ...

    Amount Raised:    $55,053.00
    Fundraising Status:    EC
    Filing Type:    CF
    BioLineRx Ltd.

    BioLineRx Ltd.

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The C...

    BioLineRx is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Akero Therapeutics, Inc.

    Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high...

    Akero aims to develop and deliver transformatio...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    NuCana plc

    NuCana plc

    We are a clinical-stage biopharmaceutical company focused on significantly improvi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    IDEAYA Biosciences, Inc.

    IDEAYA Biosciences, Inc.

    IDEAYA is an oncology-focused precision medicine company committed to the discover...

    IDEAYA is an oncology-focused precision medicin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.